Subject(s)
COVID-19 , Pneumonia, Viral , Child , Humans , Infant , Pandemics , Pneumonia, Viral/epidemiology , Risk Factors , SARS-CoV-2ABSTRACT
The spectrum of clinical manifestations of coronavirus disease 2019 in children is yet to be fully elucidated. We report the case of an infant who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and developed mild cardiovascular inflammation, a novelty for patients of very young age, that contributes to defining the puzzling nature of this disease in pediatric patients. The potential cardiovascular involvement of SARS-CoV-2 in children should always be taken into account.
Subject(s)
Coronavirus Infections , Pandemics , Pneumonia, Viral , Antibodies, Antiphospholipid , Betacoronavirus , COVID-19 , Child , Humans , Infant , SARS-CoV-2ABSTRACT
Few children have been reported to have been affected by novel coronavirus disease 2019 (COVID-19); it is unclear whether children are less likely to be infected or rather display fewer symptoms. We present the case of a 32-day-old boy infected by COVID-19 that presented with an upper air way infection which resolved spontaneously and did not require any therapy. We argue that in epidemic settings children presenting with any mild symptom potentially attributable to COVID-19 should be considered contagious until proven otherwise, and that management must be guided by clinical conditions.